Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of ovarian cancer: a pilot trial

MeSH terms

• Adolescent
• Adult
• Clinical Protocols
• Combined Modality Therapy
• DNA, Complementary / administration & dosage
• Drug Resistance, Multiple / genetics*
• Feasibility Studies
• Female
• Genetic Therapy* / adverse effects
• Hematopoietic Stem Cells / physiology*
• Humans
• Middle Aged
• Ovarian Neoplasms / therapy*
• Paclitaxel / therapeutic use
• Pilot Projects
• Reference Values
• Retroviridae / genetics*
• Transduction, Genetic